CA3304455A1 - Vaccin antitumoral chimérique ciblant la protéolyse - Google Patents

Vaccin antitumoral chimérique ciblant la protéolyse

Info

Publication number
CA3304455A1
CA3304455A1 CA3304455A CA3304455A CA3304455A1 CA 3304455 A1 CA3304455 A1 CA 3304455A1 CA 3304455 A CA3304455 A CA 3304455A CA 3304455 A CA3304455 A CA 3304455A CA 3304455 A1 CA3304455 A1 CA 3304455A1
Authority
CA
Canada
Prior art keywords
proteolysis
tumor vaccine
targeting chimera
chimera
targeting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3304455A
Other languages
English (en)
Inventor
Qiaobing Xu
Yu Zhao
Original Assignee
Tufts University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts University filed Critical Tufts University
Publication of CA3304455A1 publication Critical patent/CA3304455A1/fr
Pending legal-status Critical Current

Links

CA3304455A 2023-09-13 2024-09-13 Vaccin antitumoral chimérique ciblant la protéolyse Pending CA3304455A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/538,122 2023-09-13

Publications (1)

Publication Number Publication Date
CA3304455A1 true CA3304455A1 (fr) 2025-03-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP4125973A4 (fr) Vaccinothérapie avec des néo-antigènes
IL292272A (en) Cancer vaccine
EP3828273A4 (fr) Marqueur tumoral basé sur une modification de méthylation stamp-ep2
EP4213872A4 (fr) Vaccin à base de piv5 contre la covid-19
EP3796891A4 (fr) Constructions thérapeutiques pour le traitement du cancer
EP3904516A4 (fr) Marqueur tumoral basé sur une modification de méthylation stamp-ep6
EP4140501A4 (fr) Vaccin peptidique amélioré
EP4143738A4 (fr) Marqueur proche infrarouge de tumeur du sein
CA3304455A1 (fr) Vaccin antitumoral chimérique ciblant la protéolyse
GB202212626D0 (en) Cancer vaccine
EP4210821A4 (fr) Détermination de la position d'une tumeur
CA3281869A1 (fr) Vaccins contre tumeurs tert-positives
HK40106897A (en) Tumor neoantigenic peptides
AU2019903260A0 (en) Cancer vaccine
HK40122517A (en) Amhr2-ed cancer vaccine formulations
CA3270422A1 (fr) Vaccin amélioré
CA3299610A1 (fr) Vaccin protéique chimérique
AU2024298172A1 (en) Chimeric protein vaccine
AU2023902373A0 (en) Chimeric protein vaccine
CA3298228A1 (fr) Vaccin
AU2019901876A0 (en) Cancer vaccines
CA3280273A1 (fr) Vaccin
CA3290049A1 (fr) Vaccin contenant une chimère tp0751
HK40123327A (en) Vaccine
CA3268944A1 (fr) Vaccin